NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CFO Jay Matushak sold 4,448 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $6.74, for a total value of $29,979.52. Following the sale, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. The trade was a 9.66 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Jay Matushak also recently made the following trade(s):
- On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total value of $5,575.90.
- On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total value of $13,373.40.
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $36,430.10.
NeueHealth Stock Down 7.4 %
Shares of NYSE NEUE opened at $4.71 on Tuesday. The business's 50 day moving average price is $7.21 and its two-hundred day moving average price is $6.01. The company has a market cap of $38.98 million, a PE ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66.
Hedge Funds Weigh In On NeueHealth
A number of institutional investors have recently bought and sold shares of NEUE. Partners Group Holding AG acquired a new position in shares of NeueHealth in the third quarter valued at approximately $463,000. Northern Trust Corp grew its position in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock valued at $242,000 after purchasing an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of NeueHealth in the fourth quarter valued at approximately $76,000. Institutional investors and hedge funds own 63.88% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Monday, December 9th.
Check Out Our Latest Stock Report on NeueHealth
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
